Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind double-dummy study of CP006 dry powder inhaler in asthma
CTR20254001Phase 2Active
- Sponsor
- Shanghai New Huanghe Pharmaceutical
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CP006 in asthma, sponsored by Shanghai New Huanghe Pharmaceutical. Started Oct 2025; status: active.
02
Drugs
CP006
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20254001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254001.